Expert Speaker: Dr. Marcus Stoodley
Topic: What is the surgeon trying to achieve when treating Chiari and syringomyelia?
Please submit your questions to email@example.com. Dr. Stoodley will review all submitted questions and will answer as many as he can.
Once you have registered, you will receive login instruction in your confirmation email.
Professor Stoodley is head of neurosciences at Macquarie University Hospital. Professor Stoodley’s clinical subspecialty qualification is in neurovascular surgery. In addition to his neurovascular expertise, Professor Stoodley is recognised for clinical management and research of Chiari malformation and syringomyelia.
He graduated with honours from the University of Queensland Medical School. After completing neurosurgery training in Australia, he undertook further subspecialty training in vascular neurosurgery at Stanford University and the University of Chicago in the United States. Prior to joining Macquarie University, he worked at the Prince of Wales Hospital and the University of New South Wales.
In addition to his clinical interests, Professor Stoodley heads the neurosurgery research team at Macquarie University. This is one of the largest neurosurgery research groups in Australasia, with world-leading research efforts in syringomyelia and CSF physiology, and in the development of new treatments for brain AVMs. This work has attracted over $5 million in research funding. He has produced more than 120 publications and has supervised over 15 research students. He has delivered over 100 invited lectures at national and international scientific meetings. In 2012, Professor Stoodley was awarded the John Mitchell Crouch Fellowship by the Royal Australasian College of Surgeons, the premier surgical research award of the RACS.